Hale Hana Hana |Nā mea hana o Kina, nā mea hoʻolako - Māhele 2

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Tofacitnib Citrate

Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP

Tofacitnib Citrate Rheumatoid arthritis I-Hale

ninau kikoʻī
Sugammadex Sodium

Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP

Sugammadex Sodium Paʻa neuromuscular I-Hale

ninau kikoʻī
ʻO Sacubitril Hemicalcium

Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP

ʻO Sacubitril Hemicalcium I-Hale

ninau kikoʻī
Sofosbuvir

Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP

Sofosbuvir HCV I-Hale 32048 √

ninau kikoʻī

Ribociclib 1374639-75-4 — Ribociclib 1374639-75-4

Ka inoa o ka API Hōʻike Mea hana hou Lā Hoʻopau Patent (ʻAmelika)

Ribociclib 1374639-75-4 HR-maikaʻi, HER2-negative Andvance ormetastatic breast Cancers Novartis
ʻO nā lāʻau lapaʻau Iun.27, 2028

ninau kikoʻī

Rivaroxaban

Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP

Rivaroxaban ʻAiʻaʻa I-Hale TDP

ninau kikoʻī
ʻO Rosuvastatin Calcium

Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP

ʻO Rosuvastatin Calcium Hypercholesterolemia I-Hale/CEP 20705 √ CEP2015-240

ninau kikoʻī
ʻO Pitavastatin Calcium

Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP

ʻO Pitavastatin Calcium Hypercholesterolemia I-Hale

ninau kikoʻī
Pregabalin

Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP

Pregabalin Epilepsy/Neuralgia I-Hale/EP 22223 √ CEP2016-141

ninau kikoʻī
Obeticholic Acid

Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP

Obeticholic Acid Biliary cholangitis I-Hale

ninau kikoʻī
Niraparib 1038915-60-4

Ka inoa o ka API Hōʻike Mea hana hou Lā Hoʻopau Patent (ʻAmelika)

Niraparib 1038915-60-4 ʻOvarian/Fallopian, tube/primary peritoneal cancer Tesaro Ian.8, 2028

ninau kikoʻī
Ledipasvir Actone /PVP

Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP

Ledipasvir Actone /PVP HCV I-Hale √

ninau kikoʻī

<< < Mamua 1 2 3 4 Aʻe >>> ʻAoʻao 2 / 4